布地奈德医保给报销吗？

Will medical insurance reimburse me? Budesonide is a medical insurance drug. Budesonide is included in Category B medical insurance in the "Basic Medical Insurance Drug Catalog" and can be reimbursed by medical insurance. However, reimbursement ratios vary from place to place. For specific reimbursement information, patients can consult the local medical insurance bureau.

Budesonide is a new type of inhaled glucocorticoid asthma treatment drug, which belongs to the adrenocortical hormone class. Budesonide was first developed and marketed by AstraZeneca Pharmaceuticals in 1981. It is a non-halogenated glucocorticoid that has a strong local anti-inflammatory effect and can inhibit early bronchospasm and late allergic reactions. It is one of the important drugs for the treatment of allergic asthma. It has a highly effective local anti-inflammatory effect among similar drugs. Its efficacy is significantly stronger than that of beclomethasone propionate and other glucocorticoids. It has a long acting time and has no systemic adrenocortical hormone effect. It is more suitable for topical use. It is a first-line drug for the treatment of asthma by aerosol inhalation and the treatment of allergic reactions by spraying into the nasal cavity.

The nebulized dosage of budesonide is generally 1-2 mg once for adults, twice a day; for children, 0.5-1 mg once, twice a day. The maintenance dose should be individualized, that is, the lowest dose to maintain no symptoms. It is recommended that adults take 0.5-1 mg twice a day and children 0.25-0.5 mg twice a day. In addition, budesonide atomizer can be atomized with 1-5ml of normal saline, but atomization treatment is an auxiliary treatment method, and it is recommended not to use it for more than 3 days. If symptoms do not improve or worsen suddenly, you should seek professional medical treatment promptly. Hepatic Impairment: Consider reducing dosage to 3 mg once daily in adult patients with moderate hepatic impairment.

It is a glucocorticoid with highly effective local anti-inflammatory effects. It can enhance the stability of endothelial cells, smooth muscle cells and lysosomal membranes, inhibit immune responses and reduce antibody synthesis. It is currently one of the most commonly used drugs in the treatment of asthma in countries around the world.